EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Person looking into distance with telescope at arrow pointing upwards

UK clinical trial applications on the rise, finds MHRA

The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical R&D.
Month in pharma news, explained

Month in pharma news, explained - December 2025

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on December 2025.
Handshake

Lilly and NVIDIA: a $1bn leap for drug discovery

Eli Lilly and NVIDIA have unveiled a first-of-its-kind AI co-innovation lab, aiming to solving the most complex bottlenecks in pharma.
desktop showing data

Pharma to FDA: Upgrade cell and gene data sharing

The pharmaceutical industry is calling on the FDA to modernise how it tracks the long-term safety and efficacy of cell and gene therapies.
Two people making a handshake

J&J acquires Halda to take on cancer cell resistance

J&J successfully acquired Halda Therapeutics for $3.05bn integrating Halda’s RIPTAC platform into J&J’s oncology portfolio.
Pharma R&D cycle

End of lifelong pills? GSK’s phase 3 success in hepatitis B

GSK announced in January that its novel chronic hepatitis B successfully met primary goals in two pivotal phase 3 trials.
Vaccine administration

US slashes vaccine schedule: a major shift for paediatrics

CDC has formally reduced its routine childhood vaccine recommendations from 17 to 11, marking a major shift in US healthcare, read more.
Two US flags on beige background

Nine pharma giants sign on to Trump pricing deal

President Donald Trump has unveiled a new set of sweeping pricing deals with nine large drugmakers, according to a White House press release.
We’ve noticed you’re accessing
from North/South America.